Literature DB >> 16283096

Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.

Marcus Koch1, Geeta S M Ramsaransing, Alexander V Arutjunyan, Michael Stepanov, Albert Teelken, Dorothea J Heersema, Jacques De Keyser.   

Abstract

BACKGROUND: The role of oxidative stress in patients with multiple sclerosis (MS) is poorly understood.
OBJECTIVE: To investigate oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of MS.
METHODS: Diene conjugate (DC) levels (a measure of lipid peroxidation), total antioxidative activity (AOA) and total antiradical activity (ARA) were measured in serum and peripheral blood leukocytes from 30 patients with benign relapsing remitting MS (BMS), 27 with secondary progressive MS (SPMS), 29 with primary progressive MS (PPMS), and 30 healthy controls. All MS patients were in a clinically stable phase.
RESULTS: Serum DC levels were elevated in patients with BMS (p <0.05), SPMS (p <0.01) and PPMS (p <0.001). Serum total AOA and ARA were not different between MS patients and controls. Compared to controls, leukocyte DC levels were not different in each MS subgroup, but total ARA was elevated. There was a strong correlation, both in controls and MS patients, between leukocyte DC levels and leukocyte total ARA (p <0.0001) and leukocyte total AOA (p <0.0001).
CONCLUSION: Oxidative stress occurs in progressive as well as benign MS. The finding that cells withstand oxidative stress, due to upregulated cellular antioxidant defence mechanisms, suggests that reactive oxygen species (ROS) formation in MS is not necessarily deleterious.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283096     DOI: 10.1007/s00415-005-0037-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

Review 1.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

Authors:  Harry Ischiropoulos; Joseph S Beckman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Infrared spectroscopic characterisation of multiple sclerosis plaques in the human central nervous system.

Authors:  L P Choo; M Jackson; W C Halliday; H H Mantsch
Journal:  Biochim Biophys Acta       Date:  1993-10-20

3.  Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.

Authors:  H E Andrews; P P Nichols; D Bates; D M Turnbull
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

Review 4.  Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.

Authors:  Jacques De Keyser; Esther Zeinstra; Jop Mostert; Nadine Wilczak
Journal:  Trends Pharmacol Sci       Date:  2004-02       Impact factor: 14.819

5.  Differential regulation of antioxidant enzymes in response to oxidants.

Authors:  S Shull; N H Heintz; M Periasamy; M Manohar; Y M Janssen; J P Marsh; B T Mossman
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

6.  Tolerance of rats to hyperoxia. Lung antioxidant enzyme gene expression.

Authors:  L B Clerch; D Massaro
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

7.  Evidence for increased lipid peroxidation in multiple sclerosis.

Authors:  P K Toshniwal; E J Zarling
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

Review 8.  Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases.

Authors:  Xi-Lin Chen; Charles Kunsch
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 9.  The role of nitric oxide in multiple sclerosis.

Authors:  Kenneth J Smith; Hans Lassmann
Journal:  Lancet Neurol       Date:  2002-08       Impact factor: 44.182

10.  Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration.

Authors:  Raju Kapoor; Meirion Davies; Paul A Blaker; Susan M Hall; Kenneth J Smith
Journal:  Ann Neurol       Date:  2003-02       Impact factor: 10.422

View more
  26 in total

1.  Relationship between thiol-disulphide homeostasis and visual evoked potentials in patients with multiple sclerosis.

Authors:  Gönül Vural; Şadiye Gümüşyayla; Orhan Deniz; Salim Neşelioğlu; Özcan Erel
Journal:  Neurol Sci       Date:  2018-12-01       Impact factor: 3.307

2.  Aminoguanidine and N-acetyl-cysteine supress oxidative and nitrosative stress in EAE rat brains.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Dusica Pavlovic; Dusan Sokolovic; Ivana Stevanovic
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

Review 3.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

4.  Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Dragan Stojanov; Svetlana Stojanovic; Gordana Kocic; Dejan Savic; Tatjana Cvetkovic; Dusica Pavlovic
Journal:  Cell Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.046

5.  Examining the contributions of environmental quality to pediatric multiple sclerosis.

Authors:  Amy M Lavery; Amy T Waldman; T Charles Casper; Shelly Roalstad; Meghan Candee; John Rose; Anita Belman; Bianca Weinstock-Guttman; Greg Aaen; Jan-Mendelt Tillema; Moses Rodriguez; Jayne Ness; Yolanda Harris; Jennifer Graves; Lauren Krupp; Leslie Benson; Mark Gorman; Manikum Moodley; Mary Rensel; Manu Goyal; Soe Mar; Tanuja Chitnis; Teri Schreiner; Tim Lotze; Benjamin Greenberg; Ilana Kahn; Jennifer Rubin; Emmanuelle Waubant
Journal:  Mult Scler Relat Disord       Date:  2017-09-07       Impact factor: 4.339

6.  Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect.

Authors:  Neveen A Salem; Naglaa Assaf; Manal F Ismail; Yasser A Khadrawy; Mohga Samy
Journal:  Cell Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.046

7.  Sex Bias in Pathogenesis of Autoimmune Neuroinflammation: Relevance for Dimethyl Fumarate Immunomodulatory/Anti-oxidant Action.

Authors:  Zorica Stojić-Vukanić; Jelena Kotur-Stevuljević; Mirjana Nacka-Aleksić; Duško Kosec; Ivana Vujnović; Ivan Pilipović; Mirjana Dimitrijević; Gordana Leposavić
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

8.  Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.

Authors:  Jofre Tenorio-Laranga; Francisco Coret-Ferrer; Buenaventura Casanova-Estruch; María Burgal; J Arturo García-Horsman
Journal:  J Neuroinflammation       Date:  2010-04-06       Impact factor: 8.322

9.  Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter.

Authors:  Christel Steen; Nadine Wilczak; Johannes M Hoogduin; Marcus Koch; Jacques De Keyser
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.